Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person UniProt:Q16236 NFE2L2
| Class:Id | ReferenceGeneProduct:60145 |
|---|---|
| _chainChangeLog | chain:1-605 added on Sat February 7 2015 |
| _displayName | UniProt:Q16236 NFE2L2 |
| _timestamp | 2026-02-20 22:57:35 |
| chain | chain:1-605 |
| checksum | 99FAFD811B6C1416 |
| comment | FUNCTION Transcription factor that plays a key role in the response to oxidative stress: binds to antioxidant response (ARE) elements present in the promoter region of many cytoprotective genes, such as phase 2 detoxifying enzymes, and promotes their expression, thereby neutralizing reactive electrophiles (PubMed:11035812, PubMed:19489739, PubMed:29018201, PubMed:31398338). In normal conditions, ubiquitinated and degraded in the cytoplasm by the BCR(KEAP1) complex (PubMed:11035812, PubMed:15601839, PubMed:29018201). In response to oxidative stress, electrophile metabolites inhibit activity of the BCR(KEAP1) complex, promoting nuclear accumulation of NFE2L2/NRF2, heterodimerization with one of the small Maf proteins and binding to ARE elements of cytoprotective target genes (PubMed:19489739, PubMed:29590092). The NFE2L2/NRF2 pathway is also activated in response to selective autophagy: autophagy promotes interaction between KEAP1 and SQSTM1/p62 and subsequent inactivation of the BCR(KEAP1) complex, leading to NFE2L2/NRF2 nuclear accumulation and expression of cytoprotective genes (PubMed:20452972). The NFE2L2/NRF2 pathway is also activated during the unfolded protein response (UPR), contributing to redox homeostasis and cell survival following endoplasmic reticulum stress (By similarity). May also be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region (PubMed:7937919). Also plays an important role in the regulation of the innate immune response and antiviral cytosolic DNA sensing. It is a critical regulator of the innate immune response and survival during sepsis by maintaining redox homeostasis and restraint of the dysregulation of pro-inflammatory signaling pathways like MyD88-dependent and -independent and TNF signaling (By similarity). Suppresses macrophage inflammatory response by blocking pro-inflammatory cytokine transcription and the induction of IL6 (By similarity). Binds to the proximity of pro-inflammatory genes in macrophages and inhibits RNA Pol II recruitment. The inhibition is independent of the NRF2-binding motif and reactive oxygen species level (By similarity). Represses antiviral cytosolic DNA sensing by suppressing the expression of the adapter protein STING1 and decreasing responsiveness to STING1 agonists while increasing susceptibility to infection with DNA viruses (PubMed:30158636). Once activated, limits the release of pro-inflammatory cytokines in response to human coronavirus SARS-CoV-2 infection and to virus-derived ligands through a mechanism that involves inhibition of IRF3 dimerization. Also inhibits both SARS-CoV-2 replication, as well as the replication of several other pathogenic viruses including Herpes Simplex Virus-1 and-2, Vaccinia virus, and Zika virus through a type I interferon (IFN)-independent mechanism (PubMed:33009401).ACTIVITY REGULATION Activated by cell derived metabolites including itaconate and fumarate.ACTIVITY REGULATION (Microbial infection) Transcription factor activity on antioxidant target genes is significantly inhibited by SARS coronavirus-2/SARS-COV-2.SUBUNIT Heterodimer; heterodimerizes with small Maf proteins (By similarity). Interacts (via the bZIP domain) with MAFG and MAFK; required for binding to antioxidant response elements (AREs) on DNA (By similarity). Interacts with KEAP1; the interaction is direct and promotes ubiquitination by the BCR(KEAP1) E3 ubiquitin ligase complex (PubMed:15601839, PubMed:16888629). Forms a ternary complex with PGAM5 and KEAP1 (PubMed:18387606). Interacts with EEF1D at heat shock promoter elements (HSE) (PubMed:21597468). Interacts via its leucine-zipper domain with the coiled-coil domain of PMF1 (PubMed:11256947). Interacts with CHD6; involved in activation of the transcription (By similarity). Interacts with ESRRB; represses NFE2L2 transcriptional activity (By similarity). Interacts with MOTS-c, a peptide produced by the mitochondrially encoded 12S rRNA MT-RNR1; the interaction occurs in the nucleus following metabolic stress (PubMed:29983246).SUBUNIT (Microbial infection) Interacts with herpes virus 8 protein LANA1.INTERACTION Cytosolic under unstressed conditions: ubiquitinated and degraded by the BCR(KEAP1) E3 ubiquitin ligase complex (PubMed:15601839, PubMed:21196497). Translocates into the nucleus upon induction by electrophilic agents that inactivate the BCR(KEAP1) E3 ubiquitin ligase complex (PubMed:21196497).ALTERNATIVE PRODUCTS Widely expressed. Highest expression in adult muscle, kidney, lung, liver and in fetal muscle.INDUCTION Down-regulated by ENC1 via a proteasomal ubiquitin-independent protein catabolic process.DOMAIN The ETGE motif, and to a lower extent the DLG motif, mediate interaction with KEAP1.PTM Ubiquitinated in the cytoplasm by the BCR(KEAP1) E3 ubiquitin ligase complex leading to its degradation (PubMed:15601839, PubMed:15983046, PubMed:19489739). In response to oxidative stress, electrophile metabolites, such as sulforaphane, modify KEAP1, leading to inhibit activity of the BCR(KEAP1) complex, promoting NFE2L2/NRF2 nuclear accumulation and activity (PubMed:19489739, PubMed:29590092). In response to autophagy, the BCR(KEAP1) complex is inactivated (By similarity).PTM Phosphorylated by EIF2AK3/PERK following unfolded protein response (UPR), promoting dissociation from its cytoplasmic inhibitor KEAP1, followed by its translocation into the nucleus (By similarity). Phosphorylation of Ser-40 by PKC in response to oxidative stress dissociates NFE2L2 from its cytoplasmic inhibitor KEAP1, promoting its translocation into the nucleus (By similarity).PTM Acetylation at Lys-596 and Lys-599 increases nuclear localization whereas deacetylation by SIRT1 enhances cytoplasmic presence.PTM Glycation impairs transcription factor activity by preventing heterodimerization with small Maf proteins (PubMed:31398338). Deglycation by FN3K restores activity (PubMed:31398338).DISEASE The disease is caused by variants affecting the gene represented in this entry.SIMILARITY Belongs to the bZIP family. CNC subfamily.SEQUENCE CAUTION Truncated N-terminus.SEQUENCE CAUTION Truncated N-terminus. |
| description | recommendedName: fullName evidence="24"Nuclear factor erythroid 2-related factor 2 shortName evidence="24"NF-E2-related factor 2 shortName evidence="24"NFE2-related factor 2 shortName evidence="25"Nrf-2 alternativeName: fullName evidence="28 29"Nuclear factor, erythroid derived 2, like 2 |
| geneName | NFE2L2 NRF2 |
| identifier | Q16236 |
| isSequenceChanged | FALSE |
| keyword | 3D-structure Acetylation Activator Alternative splicing Cytoplasm Disease variant DNA-binding Glycation Glycoprotein Host-virus interaction Nucleus Phosphoprotein Proteomics identification Reference proteome Transcription Transcription regulation Ubl conjugation |
| modified | [InstanceEdit:9836292] Weiser, Joel, 2023-05-25 [InstanceEdit:9852000] Weiser, Joel, 2023-11-03 [InstanceEdit:9917590] Weiser, Joel, 2024-08-09 [InstanceEdit:9926675] Weiser, Joel, 2024-11-03 [InstanceEdit:9939033] Weiser, Joel, 2025-02-21 [InstanceEdit:9983091] Weiser, Joel, 2026-02-20 |
| name | NFE2L2 |
| referenceDatabase | [ReferenceDatabase:2] UniProt |
| referenceGene | [ReferenceDNASequence:8997851] ENSEMBL:ENSG00000116044 NFE2L2 [Homo sapiens] |
| secondaryIdentifier | NF2L2_HUMAN B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71 |
| sequenceLength | 605 |
| species | [Species:48887] Homo sapiens |
| (isoformParent) | [ReferenceIsoform:239477] UniProt:Q16236-2 NFE2L2 [Homo sapiens] [ReferenceIsoform:405903] UniProt:Q16236-1 NFE2L2 [Homo sapiens] [ReferenceIsoform:8969771] UniProt:Q16236-3 NFE2L2 [Homo sapiens] |
| (referenceEntity) | [EntityWithAccessionedSequence:201566] NFE2L2 [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:517889] NFE2L2 [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:517895] NFE2L2 [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:8932290] p-S40-NFE2L2 [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:8932311] p-S,T-NFE2L2 [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:9715109] p-S40-NFE2L2 [nucleoplasm] [Homo sapiens] [EntityWithAccessionedSequence:9715110] p-S,T-NFE2L2 [nucleoplasm] [Homo sapiens] [EntityWithAccessionedSequence:9758077] ub-NFE2L2 [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:9760018] p-S40-18 AcK-NFE2L2 [nucleoplasm] [Homo sapiens] [EntityWithAccessionedSequence:9760033] p-S,T-18 AcK-NFE2L2 [nucleoplasm] [Homo sapiens] |
| (referenceSequence) | [ModifiedResidue:8932299] [ModifiedResidue:8932316] O-phospho-L-threonine at unknown position [ModifiedResidue:8932370] O-phospho-L-serine at 40 [ModifiedResidue:8932372] O-phospho-L-serine at unknown position [GroupModifiedResidue:9758080] ubiquitinylated lysine (K48polyUb [cytosol]) at unknown position [ModifiedResidue:9760011] N6-acetyl-L-lysine at 445 [ModifiedResidue:9760012] N6-acetyl-L-lysine at 518 [ModifiedResidue:9760013] N6-acetyl-L-lysine at 462 [ModifiedResidue:9760014] N6-acetyl-L-lysine at 516 [ModifiedResidue:9760015] N6-acetyl-L-lysine at 438 |
| [Change default viewing format] | |
No pathways have been reviewed or authored by UniProt:Q16236 NFE2L2 (60145)
